FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3016401356> ?p ?o ?g. }

• W3016401356 abstract "Background and importance A hospital complex has a reference centre that is a tertiary hospital to which is attached a regional hospital located 75 km away. In 2018, in coordination with the pharmacy and haematology service, it was decided to implement a monographic consultation for patient with multiple myeloma in the regional hospital, with the proposal to improve the accessibility of patients to chemotherapeutic treatments and avoid displacement to the centre of reference. Aim and objectives To describe the activity carried out within the scope of a programme to improve accessibility for patients with multiple myeloma. User satisfaction with this new feature was evaluated. Material and methods A retrospective descriptive study was conducted in April 2018 and September 2019. The following variables of the chemotherapy management programme (Farmis-Oncofarm) were recorded: number of patients treated, number of chemotherapy cycles administered and type of chemotherapeutic scheme. To evaluate patient satisfaction, we obtained 30 anonymous and voluntary evaluations in which total satisfaction was rated from 1 to 10 and also satisfaction per item. Results A total of 46 patients were treated during the study period: 58% were men and average age was 62 years. A total of 382 cycles of parenteral chemotherapy and 145 cycles of oral chemotherapy were administered. The schemes used were: VTD (bortezomib–thalidomide–prednisone), VMP (bortezomib–melfalan–prednisone), bortezomib–dexamethasone, daratumumab–bortezomib–dexamethasone, maintenance lenalidomide and Rd (lenalidomide–dexamethasone). Overall satisfaction by patients was 9.4. The best rated items were accessibility to the centre, proximity between the different units (haematology consultation, pharmacy and oncology day hospital) and waiting time. Conclusion and relevance The implemented programme has been highly valued by patients. Seeking strategies aimed at improving the accessibility of patients to hospital treatments should be a priority for the health system. In our case, the pathology required frequent and repeated cycles of chemotherapy in fragile and elderly patients. This added to the ease of administration (subcutaneous and oral routes) making multiple myeloma a candidate pathology to follow-up in a regional hospital without jeopardising patient safety. References and/or acknowledgements No conflict of interest." @default.
• W3016401356 created "2020-04-24" @default.
• W3016401356 creator A5025728177 @default.
• W3016401356 creator A5033055030 @default.
• W3016401356 creator A5039154947 @default.
• W3016401356 creator A5062012854 @default.
• W3016401356 creator A5062695409 @default.
• W3016401356 creator A5082544515 @default.
• W3016401356 date "2020-03-01" @default.
• W3016401356 modified "2023-10-06" @default.
• W3016401356 title "4CPS-085 Improved access to chemotherapeutic treatment in patients with multiple myeloma" @default.
• W3016401356 doi "https://doi.org/10.1136/ejhpharm-2020-eahpconf.186" @default.
• W3016401356 hasPublicationYear "2020" @default.
• W3016401356 type Work @default.
• W3016401356 sameAs 3016401356 @default.
• W3016401356 citedByCount "0" @default.
• W3016401356 crossrefType "proceedings-article" @default.
• W3016401356 hasAuthorship W3016401356A5025728177 @default.
• W3016401356 hasAuthorship W3016401356A5033055030 @default.
• W3016401356 hasAuthorship W3016401356A5039154947 @default.
• W3016401356 hasAuthorship W3016401356A5062012854 @default.
• W3016401356 hasAuthorship W3016401356A5062695409 @default.
• W3016401356 hasAuthorship W3016401356A5082544515 @default.
• W3016401356 hasBestOaLocation W30164013561 @default.
• W3016401356 hasConcept C104863432 @default.
• W3016401356 hasConcept C126322002 @default.
• W3016401356 hasConcept C143998085 @default.
• W3016401356 hasConcept C2776063141 @default.
• W3016401356 hasConcept C2776364478 @default.
• W3016401356 hasConcept C2776694085 @default.
• W3016401356 hasConcept C2777478702 @default.
• W3016401356 hasConcept C2778720950 @default.
• W3016401356 hasConcept C2780401358 @default.
• W3016401356 hasConcept C512399662 @default.
• W3016401356 hasConcept C71924100 @default.
• W3016401356 hasConceptScore W3016401356C104863432 @default.
• W3016401356 hasConceptScore W3016401356C126322002 @default.
• W3016401356 hasConceptScore W3016401356C143998085 @default.
• W3016401356 hasConceptScore W3016401356C2776063141 @default.
• W3016401356 hasConceptScore W3016401356C2776364478 @default.
• W3016401356 hasConceptScore W3016401356C2776694085 @default.
• W3016401356 hasConceptScore W3016401356C2777478702 @default.
• W3016401356 hasConceptScore W3016401356C2778720950 @default.
• W3016401356 hasConceptScore W3016401356C2780401358 @default.
• W3016401356 hasConceptScore W3016401356C512399662 @default.
• W3016401356 hasConceptScore W3016401356C71924100 @default.
• W3016401356 hasLocation W30164013561 @default.
• W3016401356 hasOpenAccess W3016401356 @default.
• W3016401356 hasPrimaryLocation W30164013561 @default.
• W3016401356 hasRelatedWork W10535914 @default.
• W3016401356 hasRelatedWork W14105614 @default.
• W3016401356 hasRelatedWork W14123024 @default.
• W3016401356 hasRelatedWork W14748329 @default.
• W3016401356 hasRelatedWork W3657330 @default.
• W3016401356 hasRelatedWork W8713393 @default.
• W3016401356 hasRelatedWork W8870890 @default.
• W3016401356 hasRelatedWork W9899198 @default.
• W3016401356 hasRelatedWork W13451163 @default.
• W3016401356 hasRelatedWork W17299077 @default.
• W3016401356 isParatext "false" @default.
• W3016401356 isRetracted "false" @default.
• W3016401356 magId "3016401356" @default.
• W3016401356 workType "article" @default.